| Code | 0827E | ||||||||||
| MA number | 46/0115/22-S | ||||||||||
| Product Form: | cps mol 60x20 mg (blis.PVC/TE/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Laboratoires Bailleul S.A., Luxembourg | ||||||||||
| Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/TE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.06.2022 |
| Validity: | 14.06.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Dokument: |
retinoidy_Kontrolny zoznam pre lekarnika.pdf
|
| Dokument: |
retinoidy_Karta pacienta_pacientky.pdf
|
| Dokument: |
retinoidy_Kontrolny zoznam pre lekara a potvrdzujuci formular pacientky.pdf
|
| Dokument: |
DHPC_retinoidy_07.06.2024.pdf
|
| PIL: |
PIL_Isotiorga 20 mg mäkké kapsuly_10.2024.pdf
|
| SPC: |
SPC_Isotiorga 20 mg mäkké kapsuly_03.2025.pdf
|
| Safety feature | Yes |
| Data update: | 17.01.2023 |
